期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 21, 期 2-3, 页码 119-126出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2010.02.004
关键词
Virus delivery; Carrier cells; MSC; NSC; HSV-1; Adenovirus
资金
- National Institutes of Health [K01NS059575, R01NS064607, R21NS056203, R21NS0632901, U01 NS061811, P01 CA069246]
The systemic administration of oncolytic virus (OV) is often inefficient due to clearance of the virus by host defense mechanism and spurious targeting of non-cancer tissues through the bloodstream. Cell mediated OV delivery could hide the virus from host defenses and direct them toward tumors: Mesencymal and neural stem cells have been described to possess tumor-homing ability as well as the capacity to deliver OVs. In this review, we will focus on approaches where OV and carrier cells are utilized for cancer therapy. Effective cellular internalization and replication of OVs need to occur both in cancer and carrier cells. We thus will discuss the current challenges faced by the use of OV delivery via carrier cells. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据